NCT03936946

Brief Summary

The purpose of this study is to determine how a 28 Day Challenge influences mental health and well-being. This is a blinded study. Participants both with and without depression and anxiety, will be included. A moderation analysis will be performed to see whether changes in depression after the intervention are a function of baseline depression and anxiety levels.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2020

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2019

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 3, 2019

Completed
1.1 years until next milestone

Study Start

First participant enrolled

June 10, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2020

Completed
Last Updated

May 26, 2021

Status Verified

May 1, 2021

Enrollment Period

1 month

First QC Date

April 15, 2019

Last Update Submit

May 21, 2021

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in Patient Heath Questionnaire-9 (PHQ-9)

    The PHQ-9 is a self-administered survey used for diagnosing depression and assessing depression severity. It measures each of the 9 DSM-IV/V diagnostic criteria for depression on a 0-3 scale. Depression Severity is measured as follows: 0 none, 1-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Validity has been assessed against structured clinical interviews. PHQ-9 scores ≥10 exhibited a sensitivity of 88% and a specificity of 88% for major depression. DSM = The Diagnostic and Statistical Manual of Mental Disorders

    Baseline, 1 months

  • Change in Patient Heath Questionnaire-9 (PHQ-9)

    The PHQ-9 is a self-administered survey used for diagnosing depression and assessing depression severity. It measures each of the 9 DSM-IV/V diagnostic criteria for depression on a 0-3 scale. Depression Severity is measured as follows: 0 none, 1-4 minimal, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe. Validity has been assessed against structured clinical interviews. PHQ-9 scores ≥10 exhibited a sensitivity of 88% and a specificity of 88% for major depression. DSM = The Diagnostic and Statistical Manual of Mental Disorders

    Baseline, 3 months

  • Change in Generalized Anxiety Disorder-7 (GAD-7)

    The GAD-7 is a self report-based survey that assesses generalized anxiety disorder and severity on a 7-item scale. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. The GAD-7 was compared to diagnoses by mental health professionals. Using scores \>/= 10, It has sensitivity of 89% and specificity of 82%.

    Baseline, 1 months

  • Change in Generalized Anxiety Disorder-7 (GAD-7)

    The GAD-7 is a self report-based survey that assesses generalized anxiety disorder and severity on a 7-item scale. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively. The GAD-7 was compared to diagnoses by mental health professionals. Using scores \>/= 10, It has sensitivity of 89% and specificity of 82%.

    Baseline, 3 months

  • Change in Perceived Stress Scale-10 (PSS-10)

    The Perceived Stress Scale-10 (PSS-10) measures global perceived stress via self-report on a ten item scale. Scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Total scores ranging from 0-13 would be considered low stress. Total scores ranging from 14-26 would be considered moderate stress. Total scores ranging from 27-40 would be considered high perceived stress.

    Baseline, 1 months

  • Change in Perceived Stress Scale-10 (PSS-10)

    The Perceived Stress Scale-10 (PSS-10) measures global perceived stress via self-report on a ten item scale. Scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Total scores ranging from 0-13 would be considered low stress. Total scores ranging from 14-26 would be considered moderate stress. Total scores ranging from 27-40 would be considered high perceived stress.

    Baseline, 3 months

Study Arms (3)

Group 1--October Start Audio Content 1

EXPERIMENTAL

This group will listen to audio content 1 daily for 28 days beginning in October, and then will receive no further intervention

Behavioral: Audio Content 1

Group 2--November Start Audio Content 1

OTHER

This group will not be assigned to any interventions during the first month of the trial and will act as a passive control group at that time. They will be assigned to listen to audio content 1 daily for 28 days beginning in November.

Behavioral: Audio Content 1

Group 3--October Start Audio Content 2

SHAM COMPARATOR

This group will listen to audio content 2 daily for 28 days beginning in October, and then will receive no further intervention.

Behavioral: Audio Content 2

Interventions

Audio Content 1BEHAVIORAL

\~30 minute daily audio recordings of content 1 for 28 days

Group 1--October Start Audio Content 1Group 2--November Start Audio Content 1
Audio Content 2BEHAVIORAL

\~30 minute daily audio recordings of content 2 for 28 days

Group 3--October Start Audio Content 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English Fluency

You may not qualify if:

  • Severe hearing impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Michasel Snyder, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not be told what the intervention is until they are assigned (i.e. each group will not know what they will be listening to ahead of time or what other groups are listening to).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to Group 1, Group 2, or Group 3. Group 1 begins the 28 day challenge in October (while group 2 acts as a passive control) and Group 2 begins the 28 day challenge 1 months late (while Group 1 receives no further intervention). Group 3 will begin the 28 day challenge concurrent with Group 1, but will listen to different audio clips than Group 1 (blinded).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chairman and Professor of Genetics

Study Record Dates

First Submitted

April 15, 2019

First Posted

May 3, 2019

Study Start

June 10, 2020

Primary Completion

July 10, 2020

Study Completion

October 10, 2020

Last Updated

May 26, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

No current plan to share data

Locations